Summit Therapeutics (SMMT) Hurt Bronte Capital. Here’s Why
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
November 20th, 2024 - Hedge Fund Investor Letters News
November 20th, 2024 - Hedge Fund Investor Letters News
November 20th, 2024 - Hedge Fund Investor Letters News
November 20th, 2024 - Hedge Fund Investor Letters News
November 19th, 2024 - Hedge Fund Investor Letters News
November 19th, 2024 - Hedge Fund Investor Letters News
May 15th, 2024 - Hedge Fund Investor Letters News
May 15th, 2024 - Hedge Fund Investor Letters News
May 15th, 2024 - Hedge Fund Investor Letters News
March 5th, 2024 - Hedge Fund Investor Letters News
Returns since its inception in May 2014 (through November 14th, 2024)